GLP-1 Nausea Timeline:
When It Peaks, When It Fades.

Nausea is the most common GLP-1 side effect and the one users talk about most. It's also the one that maps most cleanly to dose kinetics — which means if you're tracking carefully, it's predictable.

This post is descriptive, not medical advice. Patterns vary between users. What's useful is knowing that the timing follows the pharmacokinetics, not random bad luck.

Nausea follows the active level, not the injection

Many people expect nausea to hit hardest on injection day, when the fresh dose goes in. It doesn't. Tirzepatide and semaglutide are subcutaneous peptides with ~6-hour absorption rises. The peak active blood level from a single dose lands roughly 24–48 hours after injection, not at the moment the needle goes in.

Nausea tends to peak with the active level, not with the act of injecting. For weekly GLP-1s, that means:

• Inject Monday morning → nausea tends to peak Tuesday night / Wednesday morning.
• Nausea typically fades as the active level comes down over the following 3–4 days.
• By day 5–6 post-injection, most users are close to baseline comfort.

Why dose escalation weeks are harder

Tirzepatide and semaglutide both titrate — you step up every 4 weeks. The dose-escalation week is when the active level curve is climbing to a new steady state, not just maintaining one. Your active blood level is rising week over week until it plateaus ~4 weeks into the new dose.

This is why nausea often ramps for 2–3 weeks after a dose bump, then stabilizes. It's not that the drug got stronger in your body overnight. The stack kept climbing, and your receptors adapted at their own pace.

A typical nausea profile after a dose escalation

When to hold at a dose instead of stepping up

Standard guidance: titrate every 4 weeks if tolerable. "Tolerable" is a user judgment. Reasons to hold:

• Week 4 nausea is still at week 1–2 levels → receptors haven't adapted; adding more drug won't help.
• Daily food intake has fallen below a sustainable minimum (typically <1000 kcal consistently).
• Dehydration or gastrointestinal symptoms severe enough to disrupt work or sleep.
• Weekly weight loss exceeds ~1% of body weight consistently for 3+ weeks (too aggressive for lean-mass retention).

Holding a dose doesn't mean you stopped progress. At steady state on the current dose, your active level stops climbing but appetite suppression continues. Most users who hold 4 extra weeks don't regain weight — they just decelerate loss.

Foods that commonly become harder

• High-fat meals — delayed gastric emptying makes them sit longer.
• Fried foods — same mechanism, often worse.
• Large portions — volume matters more than macros on GLP-1s. Same calories split into two meals is often tolerable when one meal isn't.
• Alcohol — many users report new sensitivity. Dehydration compounds nausea.
• Sugary drinks on an empty stomach — glucose spikes without solid food often trigger nausea.

What tends to still work

• Small, frequent, protein-forward meals.
• Cold or room-temp foods (often tolerated better than hot).
• Ginger — multiple small trials support it. A ginger chew before meals.
• Hydration — not the fix people think, but dehydration reliably makes it worse.
• Eating within ~2 hours of waking, before peak symptoms.

Why tracking helps here

If you log nausea severity daily on a 0–10 scale along with your injection timing, patterns become visible. You'll see your personal peak day (often +1 or +2). You'll see dose-escalation weeks light up against maintenance weeks. You'll see food correlations that aren't obvious day-to-day but are clear over a month.

That's not data for its own sake. That's the data that tells you whether to hold, titrate, or adjust timing — and the data your physician actually wants to see when deciding next steps.